306 related articles for article (PubMed ID: 24944468)
1. Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.
Scarpa M; Castagliuolo I; Castoro C; Pozza A; Scarpa M; Kotsafti A; Angriman I
World J Gastroenterol; 2014 Jun; 20(22):6774-85. PubMed ID: 24944468
[TBL] [Abstract][Full Text] [Related]
2. Colonic carcinogenesis in IBD: molecular events.
Pozza A; Scarpa M; Ruffolo C; Polese L; Erroi F; Bridda A; Norberto L; Frego M
Ann Ital Chir; 2011; 82(1):19-28. PubMed ID: 21657151
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NFκB signalling.
Scarpa M; Cardin R; Bortolami M; Kotsafti A; Scarpa MC; Pozza A; Maran G; Picciocchi M; Ruffolo C; D'Incà R; Sturniolo GC; Castagliuolo I; Castoro C; Angriman I
Eur J Cancer; 2013 Jan; 49(1):254-63. PubMed ID: 22704122
[TBL] [Abstract][Full Text] [Related]
5. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
6. CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis.
Scarpa M; Brun P; Scarpa M; Morgan S; Porzionato A; Kotsafti A; Bortolami M; Buda A; D'Incà R; Macchi V; Sturniolo GC; Rugge M; Bardini R; Castagliuolo I; Angriman I; Castoro C
Oncotarget; 2015 Aug; 6(24):20058-69. PubMed ID: 25595911
[TBL] [Abstract][Full Text] [Related]
7. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
Gushima M; Hirahashi M; Matsumoto T; Fujita K; Ohuchida K; Oda Y; Yao T; Iida M; Tsuneyoshi M
Histopathology; 2011 Sep; 59(3):460-9. PubMed ID: 22034886
[TBL] [Abstract][Full Text] [Related]
8. Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis.
Gerling M; Nousiainen K; Hautaniemi S; Krüger S; Fritzsche B; Homann N; Bruch HP; Auer G; Roblick UJ; Ried T; Habermann JK
Inflamm Bowel Dis; 2013; 19(4):691-703. PubMed ID: 23455720
[TBL] [Abstract][Full Text] [Related]
9. Wnt pathway-related gene expression during malignant progression in ulcerative colitis.
van Dekken H; Wink JC; Vissers KJ; Franken PF; Ruud Schouten W; J Hop WC; Kuipers EJ; Fodde R; Janneke van der Woude C
Acta Histochem; 2007; 109(4):266-72. PubMed ID: 17445872
[TBL] [Abstract][Full Text] [Related]
10. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
Tahara T; Hirata I; Nakano N; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
Inflamm Bowel Dis; 2017 Jan; 23(1):165-173. PubMed ID: 27930411
[TBL] [Abstract][Full Text] [Related]
12. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of colitis-associated neoplasms].
Vieth M; Neumann H
Pathologe; 2012 Nov; 33 Suppl 2():215-20. PubMed ID: 23052342
[TBL] [Abstract][Full Text] [Related]
14. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
16. Chronic ulcerative colitis and colorectal cancer.
Rogler G
Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.
Ueda Y; Ando T; Nanjo S; Ushijima T; Sugiyama T
Dig Dis Sci; 2014 Oct; 59(10):2444-51. PubMed ID: 24825593
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
19. Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis.
Friis-Ottessen M; Bendix L; Kølvraa S; Norheim-Andersen S; De Angelis PM; Clausen OP
BMC Gastroenterol; 2014 Jan; 14():8. PubMed ID: 24405569
[TBL] [Abstract][Full Text] [Related]
20. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
